Comments

Rezolute Stock Price, Quotes and Forecasts

Q: What sector and industry does Rezolute (RZLT) operate in?

Rezolute is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

RZLTNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$3.95

0.153.95%

At close: -

$3.78

-0.17-4.30%

After Hours: 7:36 PM EDT

Rezolute (RZLT) Forecast

News Earnings Rezolute (RZLT) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Rezolute Stock Price, Quotes and Forecasts | NASDAQ:RZLT | Benzinga

Explore Rezolute stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RZLT.

Open	$3.80
Close	$3.95
Volume / Avg.	706.50K / 992.93K
Day Range	$3.67 - $3.96
52 Wk Range	2.22 - 6.19
Market Cap	$323.27M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	57
Short Interest	4.96%
Days to Cover	1.3

Recent News

Rezolute 'Thrilled' With Positive Review Of Genetic Disorder Trial, Expects Topline Results In December

Rezolute advances HI drug trial after DMC review and secures $90 million in funding through stock offering to support development.

Vandana Singh

Why AZEK Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

FDA Gives Green Signal To Rezolute's Genetic Disorder Treatment

FDA lifts clinical hold on Rezolute's RZ358 for treating congenital hyperinsulinism, allowing U.S. participants in Phase 3 study. Enrollment expected to start in 2025 with topline data by mid-year.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$3.80
Close	$3.95
Volume / Avg.	706.50K / 992.93K
Day Range	$3.67 - $3.96
52 Wk Range	2.22 - 6.19
Market Cap	$323.27M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	57
Short Interest	4.96%
Days to Cover	1.3

About Rezolute Inc

Sector

Health Care

Industry

Biotechnology

Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectabl...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Rezolute (RZLT) stock?

You can purchase shares of Rezolute (NASDAQ:RZLT) through any online brokerage.

View our list of the best stock brokerages

Who are Rezolute (RZLT) competitors?

Other companies in Rezolute’s space includes: Humacyte (NASDAQ:HUMA), CytomX Therapeutics (NASDAQ:CTMX), aTyr Pharma (NASDAQ:ATYR), Neurogene (NASDAQ:NGNE) and Olema Pharmaceuticals (NASDAQ:OLMA).

What is the forecast, or price target, for Rezolute (RZLT) stock?

Rezolute has a consensus price target of $11.70.

What is the current price for Rezolute (RZLT)?

The stock price for Rezolute (NASDAQ: RZLT) is $3.7801 last updated May 20, 2025 at 7:36 PM EDT.

Does Rezolute (RZLT) pay a dividend?

There are no upcoming dividends for Rezolute.

When is Rezolute (NASDAQ:RZLT) reporting earnings?

Rezolute’s Q3 earnings are confirmed for Tuesday, May 13, 2025.

Is Rezolute (RZLT) going to split?

There is no upcoming split for Rezolute.

What sector and industry does Rezolute (RZLT) operate in?

Rezolute is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.